ISSN: 1573-4099

Journal Home

Journal Guideline

Current Computer-Aided Drug Design Q3 Unclaimed

Bentham Science Publishers United Arab Emirates

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Computer-Aided Drug Design is a journal indexed in SJR in Medicine (miscellaneous) and Drug Discovery with an H index of 35. It has an SJR impact factor of 0,294 and it has a best quartile of Q3. It has an SJR impact factor of 0,294.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q3) Drug Discovery (Q4) Molecular Medicine (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,294

SJR Impact factor

35

H Index

96

Total Docs (Last Year)

160

Total Docs (3 years)

4826

Total Refs

273

Total Cites (3 years)

155

Citable Docs (3 years)

1.63

Cites/Doc (2 years)

50.27

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Canadian Respiratory Journal Q3
Current Stem Cell Research and Therapy Q3
Polish Journal of Microbiology Q3
JMIR Research Protocols Q3
Deutsches AÃàrzteblatt international Q3

Compare this journals

Aims and Scope

Best articles by citations

A Combined Cheminformatics and Computational Approach for the Prediction of Anti-HIV Small Molecules

Discovery of novel compounds targeting DJ-1 as neuroprotectants for Parkinson's disease by virtual screening and in silico method

Finding Relevant Genes Involved in the Cytotoxicity Mechanisms of Anticancer Biophores

In silico and in vitro studies of natural compounds as human CK2 inhibitors

Calmodulin in Complex with Proteins and Small Molecule Ligands: Operating with the Element of Surprise; Implications for Structure-Based Drug Design

Fragment-Based Development of HCV Protease Inhibitors for the Treatment of Hepatitis C

Editorial: The Concepts of Pharmacophore/Toxicophores: A Philosophical/Mathematical- cum-Historical Perspective

Hybrid Usage of Computational Tools in Drug Synthesis

Explicit Treatment of Water Molecules in Protein-Ligand Docking

Theoretical Modeling of HPV: QSAR and Novodesign with Fragment Approach

In-vitro and In-silico analysisof anti-diabetic and anti-microbial activity of Cichorium intybus leaf extracts

Development of QSPR Strategy for the Solubility Prediction

SHOW MORE ARTICLES

Computational Approaches for Fragment Optimization

Discovery of Potent Anti-SARS-CoV MPro Inhibitors

Experimental and Computational Studies on the Inhibition of Acetylcholinesterase by Curcumin and Some of its Derivatives

Recent Advances in Ligand-Based Drug Design: Relevance and Utility of the Conformationally Sampled Pharmacophore Approach

Editorial: The Importance of Rigorous Statistical Practice in the Current Landscape of QSAR Modelling

Subset Selection and Docking of Human P2X7 Inhibitors

Molecular Topological Properties of Alkylating Agents Based Anticancer Drug Candidates Via Some Ve-degree Topological Indices

Pharmacophore Based 3DQSAR of Phenothiazines as Specific Human Butyrylcholinesterase Inhibitors for Treatment of Alzheimer's Disease

Refinement of Protein Structure Predicted Models Using Minimum Spanning Tree

Current Development on HIV-1 Protease Inhibitors

Author Index To Volume 2

Editorial: An Emerging Immunogenomics and Computational Approach for Peptide Vaccinology: Rational Design of Peptide Vaccines